Social cognition in chronic migraine with medication overuse: a cross-sectional study on different aspects of mentalization and social relationships.
Chronic migraine
Medication overuse headache
Socio-cognitive dimensions
Theory of mind
Journal
The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562
Informations de publication
Date de publication:
28 Apr 2023
28 Apr 2023
Historique:
received:
22
03
2023
accepted:
13
04
2023
medline:
1
5
2023
pubmed:
28
4
2023
entrez:
27
4
2023
Statut:
epublish
Résumé
Social cognition refers to all mental operations to decipher information needed in social interactions. Here we aimed to outline the socio-cognitive profile of Chronic Migraine with Medication Overuse (CM + MO), given they are recognized to be at risk of socio-cognitive difficulties. Given the multidimensionality of this construct, we considered: (1) socio-cognitive abilities, (2) socio-cognitive beliefs, (3) alexithymia and autism traits, and (4) social relationships. Seventy-one patients suffering from CM + MO, 61 from episodic migraine (EM), and 80 healthy controls (HC) were assessed with a comprehensive battery: (1) the Faux Pas test (FP), the Strange Stories task (SS), the Reading Mind in the Eyes test (RMET), (2) the Tromsø Social Intelligence Scale, (3) the Toronto Alexithymia Scale, the Autism Spectrum Quotient, (4) the Lubben Social Network Scale, the Friendship Scale. CM + MO: (1) performed similar to EM but worse than HC in the FP and SS, while they were worse than EM and HC in the RMET; (2) were similar to EM and HC in social intelligence; (3) had more alexithymic/autistic traits than EM and HC; (4) reported higher levels of contact with their family members but felt little support from the people around them than HC. CM + MO results characterized by a profile of compromised socio-cognitive abilities that affects different dimensions. These findings may have a relevant role in multiple fields related to chronic headache: from the assessment to the management.
Sections du résumé
BACKGROUND
BACKGROUND
Social cognition refers to all mental operations to decipher information needed in social interactions. Here we aimed to outline the socio-cognitive profile of Chronic Migraine with Medication Overuse (CM + MO), given they are recognized to be at risk of socio-cognitive difficulties. Given the multidimensionality of this construct, we considered: (1) socio-cognitive abilities, (2) socio-cognitive beliefs, (3) alexithymia and autism traits, and (4) social relationships.
METHODS
METHODS
Seventy-one patients suffering from CM + MO, 61 from episodic migraine (EM), and 80 healthy controls (HC) were assessed with a comprehensive battery: (1) the Faux Pas test (FP), the Strange Stories task (SS), the Reading Mind in the Eyes test (RMET), (2) the Tromsø Social Intelligence Scale, (3) the Toronto Alexithymia Scale, the Autism Spectrum Quotient, (4) the Lubben Social Network Scale, the Friendship Scale.
RESULTS
RESULTS
CM + MO: (1) performed similar to EM but worse than HC in the FP and SS, while they were worse than EM and HC in the RMET; (2) were similar to EM and HC in social intelligence; (3) had more alexithymic/autistic traits than EM and HC; (4) reported higher levels of contact with their family members but felt little support from the people around them than HC.
CONCLUSIONS
CONCLUSIONS
CM + MO results characterized by a profile of compromised socio-cognitive abilities that affects different dimensions. These findings may have a relevant role in multiple fields related to chronic headache: from the assessment to the management.
Identifiants
pubmed: 37106347
doi: 10.1186/s10194-023-01578-1
pii: 10.1186/s10194-023-01578-1
pmc: PMC10139829
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
47Informations de copyright
© 2023. The Author(s).
Références
J Headache Pain. 2016;17:39
pubmed: 27093870
J Am Acad Psychoanal. 1982 Jan;10(1):27-46
pubmed: 6896047
J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):636-41
pubmed: 11032616
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
Pain Res Manag. 2019 Jun 12;2019:1874078
pubmed: 31281555
J Headache Pain. 2011 Feb;12(1):71-80
pubmed: 20730593
Front Neurol. 2022 Aug 26;13:968111
pubmed: 36119667
Int J Methods Psychiatr Res. 2005;14(1):29-42
pubmed: 16097398
Pain Ther. 2022 Dec;11(4):1085-1094
pubmed: 35930220
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Psychiatry Res. 2007 Jan 15;149(1-3):11-23
pubmed: 17107716
Malays Fam Physician. 2008 Aug 31;3(2):82-6
pubmed: 25606122
Psychol Med. 2012 Nov;42(11):2453-9
pubmed: 22475181
J Headache Pain. 2021 Apr 21;22(1):29
pubmed: 33882816
Health Psychol. 1994 Sep;13(5):432-9
pubmed: 7805638
Cephalalgia. 2006 Feb;26(2):194-201
pubmed: 16426275
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
J Psychosom Res. 2022 Dec;163:111048
pubmed: 36228434
Mol Autism. 2016 Nov 11;7:46
pubmed: 27895883
Rev Neurol (Paris). 2021 Oct;177(8):995-1000
pubmed: 33454126
R Soc Open Sci. 2016 Oct 12;3(10):150664
pubmed: 27853532
Front Psychol. 2018 May 14;9:704
pubmed: 29867669
Neurol Sci. 2005 May;26 Suppl 2:s87-91
pubmed: 15926029
Headache. 2006 Oct;46 Suppl 3:S76-87
pubmed: 17034402
J Clin Psychol. 2015 Feb;71(2):117-24
pubmed: 25557317
J Abnorm Psychol. 2018 Aug;127(6):612-622
pubmed: 30102067
Neurol Ther. 2023 Mar 5;:
pubmed: 36871256
Br J Gen Pract. 1993 Aug;43(373):349-50
pubmed: 8251223
Cephalalgia. 2021 Dec;41(14):1437-1446
pubmed: 34256651
Int J Lang Commun Disord. 2021 Jul;56(4):841-857
pubmed: 34121295
Headache. 1993 Jun;33(6):307-14
pubmed: 8349473
J Ment Health. 2017 Jun;26(3):192-196
pubmed: 26732465
Neurol Sci. 2019 May;40(Suppl 1):187-189
pubmed: 30843117
Psychiatry Res. 2014 Apr 30;216(1):137-45
pubmed: 24534122
Scand J Psychol. 2001 Sep;42(4):313-9
pubmed: 11547906
Front Neurol. 2019 Jul 17;10:774
pubmed: 31379724
Cephalalgia. 2022 Mar;42(3):209-217
pubmed: 34541932
Neuropsychologia. 2007 Oct 1;45(13):3054-67
pubmed: 17640690
Psychol Med. 2022 Jun;52(8):1458-1470
pubmed: 33028432
J Psychosom Res. 1996 Dec;41(6):551-9
pubmed: 9032718
Psychol Sci. 2013 May;24(5):723-32
pubmed: 23528789
J Headache Pain. 2021 Oct 2;22(1):114
pubmed: 34600468
Cephalalgia. 2019 Jan;39(1):135-147
pubmed: 29945464
Handb Clin Neurol. 2020;173:255-264
pubmed: 32958179
Cortex. 2016 Aug;81:215-20
pubmed: 27253723
Cephalalgia. 2021 Nov;41(13):1318-1331
pubmed: 34162255
Front Neurol. 2017 Dec 14;8:650
pubmed: 29312108
Cephalalgia. 2018 Dec;38(14):2045-2057
pubmed: 29635935
J Child Psychol Psychiatry. 2001 Feb;42(2):241-51
pubmed: 11280420
Cephalalgia. 2016 Dec;36(14):1356-1365
pubmed: 26879321
Curr Pain Headache Rep. 2016 Apr;20(4):26
pubmed: 26936357
Minerva Pediatr. 2007 Dec;59(6):745-54
pubmed: 17978783
J Cogn Neurosci. 1998 Sep;10(5):640-56
pubmed: 9802997
Child Dev. 2009 Jul-Aug;80(4):1097-117
pubmed: 19630896
Neurology. 2015 Jan 13;84(2):132-40
pubmed: 25540306
J Autism Dev Disord. 2012 Apr;42(4):625-33
pubmed: 21626054
Int J Psychol. 2013;48(4):715-27
pubmed: 22515730
Psychol Med. 2020 Apr;50(5):754-760
pubmed: 30919788
Psychother Psychosom. 2013;82(3):190-2
pubmed: 23548987
Cephalalgia. 2013 May;33(7):431-43
pubmed: 23444078
Headache. 1993 Jun;33(6):301-6
pubmed: 8349472
Eur J Paediatr Neurol. 2022 Mar;37:68-74
pubmed: 35134658
Neuropsychology. 2022 Nov;36(8):753-763
pubmed: 36048070
Headache. 2010 Feb;50(2):198-209
pubmed: 20039955
Can J Psychiatry. 2000 Mar;45(2):134-42
pubmed: 10742872
Headache. 2002 Mar;42(3):178-84
pubmed: 11903540
Front Neurol. 2019 Mar 07;10:173
pubmed: 30899242
J Headache Pain. 2012 Nov;13(8):595-606
pubmed: 23001069
J Headache Pain. 2022 Aug 11;23(1):100
pubmed: 35953769
J Pers. 2011 Oct;79(5):1149-75
pubmed: 21241306
J Psychosom Res. 2015 Mar;78(3):228-36
pubmed: 25598410
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Front Neurol. 2021 Jul 12;12:706639
pubmed: 34322089